4crc
From Proteopedia
(Difference between revisions)
Line 6: | Line 6: | ||
Description: Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design | Description: Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design | ||
+ | [[Category: Unreleased Structures]] | ||
+ | [[Category: Tigerstrom, A]] | ||
+ | [[Category: Roth, R]] | ||
+ | [[Category: Gustafsson, D]] | ||
+ | [[Category: Nilsson, I]] | ||
+ | [[Category: Kang, D]] | ||
+ | [[Category: Karis, D]] | ||
+ | [[Category: Oster, L]] | ||
+ | [[Category: Akkaya, S]] | ||
+ | [[Category: Olsson, T]] | ||
+ | [[Category: Knecht, W]] | ||
+ | [[Category: Beisel, H.G]] | ||
+ | [[Category: Nerme, V]] | ||
+ | [[Category: Jurva, U]] | ||
+ | [[Category: Erixon, K]] | ||
+ | [[Category: Fjellstrom, O]] | ||
+ | [[Category: Eriksson, P.O]] | ||
+ | [[Category: Redzic, A]] | ||
+ | [[Category: Sandmark, J]] |
Revision as of 13:28, 24 December 2014
Unreleased structure
The entry 4crc is ON HOLD until Paper Publication
Authors: Sandmark, J., Oster, L., Fjellstrom, O., Akkaya, S., Beisel, H.G., Eriksson, P.O., Erixon, K., Gustafsson, D., Jurva, U., Kang, D., Karis, D., Knecht, W., Nerme, V., Nilsson, I., Olsson, T., Redzic, A., Roth, R., Tigerstrom, A.
Description: Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design
Categories: Unreleased Structures | Tigerstrom, A | Roth, R | Gustafsson, D | Nilsson, I | Kang, D | Karis, D | Oster, L | Akkaya, S | Olsson, T | Knecht, W | Beisel, H.G | Nerme, V | Jurva, U | Erixon, K | Fjellstrom, O | Eriksson, P.O | Redzic, A | Sandmark, J